Yaghoubi Alireza, Ghojazadeh Morteza, Abolhasani Sakhavat, Alikhah Hossein, Khaki-Khatibi Fatemeh
Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
J Cardiovasc Thorac Res. 2015;7(3):113-7. doi: 10.15171/jcvtr.2015.24.
Vitronectin (VN), malondialdehyde (MDA) and high-sensitivity C-reactive rotein (hs-CRP) are cooperative agents involved in the atherosclerosis process. The study was conducted to assess the correlation of VN, MDA and hs-CRP with the severity of coronary artery disease (CAD).
Parameters such as serum VN, MDA and hs-CRP were measured in 250 subjects including 200 patients with angiographically diagnosed CAD (50 subjects with non-significant CAD, 50 with single vessel disease, 50 with double vessel disease, and 50 with triple vessel disease) and 50 CAD-free subjects as a control group. Serum VN was measured with ELISA; MDA was measured based on reaction with thiobarbituric acid (TBA); and hs-CRP level was measured by a Commercial Kit by Immunoturbidimetry.
Serum VN, MDA and hs-CRP were significantly higher in patient groups compared to control group (P < .05). The mean value of MDA between 1 vessel and 3 vessel groups had significant difference (P = .01), also mean value of MDA between 2 vessel and control group and normal group showed significant difference (P < .001). The difference of MDA between 3 vessel and normal and 1 vessel and control group was significant (P < .001).
The association and correlation between VN, MDA and hs-CRP indicate their involvement in the atherosclerosis process that may lead to progression of CAD. Also, these findings suggested that serum levels of VN, MDA and hs-CRP can help as diagnostic and monitoring markers in CAD patients and as markers of disease severity.
玻连蛋白(VN)、丙二醛(MDA)和高敏C反应蛋白(hs-CRP)是参与动脉粥样硬化过程的协同因子。本研究旨在评估VN、MDA和hs-CRP与冠状动脉疾病(CAD)严重程度的相关性。
对250名受试者进行血清VN、MDA和hs-CRP等参数检测,其中包括200例经血管造影诊断为CAD的患者(50例非显著性CAD患者、50例单支血管病变患者、50例双支血管病变患者和50例三支血管病变患者)以及50例无CAD的受试者作为对照组。采用酶联免疫吸附测定法(ELISA)检测血清VN;基于与硫代巴比妥酸(TBA)的反应测定MDA;采用免疫比浊法通过商业试剂盒检测hs-CRP水平。
与对照组相比,患者组的血清VN、MDA和hs-CRP显著更高(P <.05)。单支血管组和三支血管组之间的MDA平均值存在显著差异(P =.01),双支血管组与对照组及正常组之间的MDA平均值也显示出显著差异(P <.00)。三支血管组与正常组以及单支血管组与对照组之间的MDA差异显著(P <.001)。
VN、MDA和hs-CRP之间的关联和相关性表明它们参与了可能导致CAD进展的动脉粥样硬化过程。此外,这些发现表明血清VN、MDA和hs-CRP水平可作为CAD患者的诊断和监测标志物以及疾病严重程度的标志物。